[Uterine hemorrhage during intrauterine contraception. Pathophysiology and therapy].
D000614:Aminocaproates / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D010450:Endopeptidases; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D005549:Foreign-Body Reaction; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects*; D007436:Intrauterine Devices, Medicated; D014592:Uterine Hemorrhage / Q000188:drug therapy / Q000209:etiology*
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D004791:Enzyme Inhibitors; D007611:Aprotinin; D010450:Endopeptidases
Uterine Blutungen bei intrauteriner Kontrazeption Pathophysiologie und Therapie.